Summary of stock option activity |
The following tables summarize the Company’s stock option and restricted stock units, (“RSUs”), activity since December 31, 2020 (in thousands, except for share and per share data):
Stock Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
Weighted
|
|
Average
|
|
|
|
|
|
|
|
Average
|
|
Remaining
|
|
Aggregate
|
|
|
Number of
|
|
Exercise
|
|
Contractual
|
|
Intrinsic
|
|
|
Shares
|
|
Price
|
|
Term
|
|
Value
|
Outstanding as of December 31, 2020
|
|
49,679,554
|
|
$
|
0.14
|
|
8.24
|
|
$
|
1,073
|
Granted
|
|
17,130,123
|
|
|
0.16
|
|
9.78
|
|
|
49,335
|
Exercised
|
|
4,137,451
|
|
|
0.11
|
|
6.72
|
|
|
12,123
|
Forfeited
|
|
75,000
|
|
|
0.16
|
|
—
|
|
|
216
|
Outstanding as of March 31, 2021
|
|
62,597,226
|
|
$
|
0.15
|
|
8.60
|
|
$
|
169,734
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as of March 31, 2021
|
|
62,597,226
|
|
$
|
0.15
|
|
8.60
|
|
$
|
169,734
|
Options exercisable as of March 31, 2021
|
|
22,901,452
|
|
$
|
0.13
|
|
7.36
|
|
$
|
66,545
|
|
The following table summarizes the Company’s stock option activity since December 31, 2019 (in thousands, except for share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
Weighted
|
|
Average
|
|
|
|
|
|
Number of
|
|
Average
|
|
Remaining
|
|
Aggregate
|
|
|
Shares
|
|
Exercise Price
|
|
Contractual Term
|
|
Intrinsic Value
|
|
|
|
|
|
|
|
(in years)
|
|
|
|
Outstanding as of December 31, 2019
|
|
29,488,684
|
|
$
|
0.12
|
|
7.90
|
|
$
|
1,149
|
Granted
|
|
24,558,325
|
|
|
0.16
|
|
9.63
|
|
|
—
|
Exercised
|
|
(3,236,374)
|
|
|
0.14
|
|
6.60
|
|
|
75
|
Forfeited
|
|
(1,131,081)
|
|
|
0.15
|
|
—
|
|
|
14
|
Outstanding as of December 31, 2020
|
|
49,679,554
|
|
$
|
0.14
|
|
8.24
|
|
$
|
1,073
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as of December 31, 2019
|
|
29,488,684
|
|
$
|
0.12
|
|
7.90
|
|
$
|
1,149
|
Options exercisable as of December 31, 2019
|
|
15,663,415
|
|
$
|
0.11
|
|
7.28
|
|
$
|
817
|
Vested and expected to vest as of December 31, 2020
|
|
49,679,554
|
|
$
|
0.14
|
|
8.24
|
|
$
|
1,073
|
Options exercisable as of December 31, 2020
|
|
26,519,727
|
|
$
|
0.12
|
|
7.12
|
|
$
|
1,224
|
|
Schedule of stock-based compensation expense |
Stock-based compensation expense was classified by award type in the consolidated statements of operations and comprehensive loss as follows (in thousands):
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
March 31,
|
|
|
2021
|
|
2020
|
Stock options
|
|
$
|
203
|
|
$
|
62
|
Warrants
|
|
|
807
|
|
|
—
|
Restricted stock units
|
|
|
72
|
|
|
—
|
Total stock-based compensation expense
|
|
$
|
1,082
|
|
$
|
62
|
|
Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2020
|
|
2019
|
Cost of revenue
|
|
$
|
10
|
|
$
|
2
|
Sales and marketing
|
|
|
104
|
|
|
170
|
General and administrative
|
|
|
370
|
|
|
74
|
Research and development
|
|
|
178
|
|
|
18
|
Total stock-based compensation expense
|
|
$
|
662
|
|
$
|
264
|
|